Standout Papers

Cereblon is a direct protein target for immunomodulatory and an... 2005 2026 2012 2019 587
  1. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide (2012)
    Antonia Lopez‐Girona, Derek Mendy et al. Leukemia
  2. Keynote review: Phosphodiesterase-4 as a therapeutic target (2005)
    Miles D. Houslay, Peter Schäfer et al. Drug Discovery Today
  3. Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN (2013)
    Anita K. Gandhi, Jian Kang et al. British Journal of Haematology

Immediate Impact

13 by Nobel laureates 23 from Science/Nature 89 standout
Sub-graph 1 of 18

Citing Papers

Targeted protein degradation: from mechanisms to clinic
2024 Standout
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity
2024 Standout
53 intermediate papers

Works of Peter Schäfer being referenced

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
2017
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN
2013 Standout
and 22 more

Author Peers

Author Last Decade Papers Cites
Peter Schäfer 4590 2846 2251 2578 203 10.7k
John H. Kersey 3713 4451 3418 2628 206 12.7k
Anders Waage 3465 2945 2928 2364 176 9.7k
R.J. Arceci 5071 2994 1945 3514 389 12.3k
Zwi Berneman 4641 2247 4568 3638 313 12.9k
William Krivit 3589 4138 1855 1678 279 14.4k
Jacqueline Whang‐Peng 5578 1639 1545 4959 314 14.8k
Giorgio Zauli 6037 1524 3864 2705 380 12.8k
Arndt Borkhardt 4531 2769 1820 1695 334 10.0k
Nelson J. Chao 2017 5307 3582 2720 336 10.8k
G Rovera 5475 2324 2495 1965 164 11.0k

All Works

Loading papers...

Rankless by CCL
2026